CALR and acute myeloid leukemia: In primary AML blasts and the HL-60 leukemic cell line, treatments with Etoposide (ETO) and Daunorubicin (DNR) can induce ICD mechanisms through the exposure on the cell surface of both CALR and HSPs and also induce the release of HMGB1 and ATP [141].